Dr. Michael Nishimura, PhD
Claim this profileStudies Skin Cancer
Studies Melanoma
1 reported clinical trial
1 drug studied
Area of expertise
1Skin Cancer
Stage IV
V600E positive
tyrosinase positive
2Melanoma
Stage IV
V600E positive
tyrosinase positive
Clinical Trials Michael Nishimura, PhD is currently running
More about Michael Nishimura, PhD
Clinical Trial Related10 years of experience running clinical trials · Led 1 trial as a Principal Investigator · 1 Active Clinical TrialTreatments Michael Nishimura, PhD has experience with
- Autologous TIL 1383I TCR Gene Modified T Cells
Breakdown of trials Michael Nishimura, PhD has run
Skin Cancer
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Michael Nishimura, PhD specialize in?
Michael Nishimura, PhD focuses on Skin Cancer and Melanoma. In particular, much of their work with Skin Cancer has involved Stage IV patients, or patients who are V600E positive.
Is Michael Nishimura, PhD currently recruiting for clinical trials?
Yes, Michael Nishimura, PhD is currently recruiting for 1 clinical trial in the USA. If you're interested in participating, you should apply.
Are there any treatments that Michael Nishimura, PhD has studied deeply?
Yes, Michael Nishimura, PhD has studied treatments such as Autologous TIL 1383I TCR Gene Modified T Cells.
What is the best way to schedule an appointment with Michael Nishimura, PhD?
Apply for one of the trials that Michael Nishimura, PhD is conducting.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.